Valor Predictivo Monitoreo Fetal
Valor Predictivo Monitoreo Fetal
Valor Predictivo Monitoreo Fetal
EUROBS 01282
Summary
The predictive value of fetal heart-rate monitoring on fetal well-being was studied in 2165 high-risk
pregnancies. 1883 reactive nonstress test (NST) patterns and 278 nonreactive NST patterns and 4 cases
of sinusoidal pattern were obtained. Oxytocin challenge test (OCT) was applied to 263 nonreactive cases.
OCT was not applied to 15 cases out of 278 nonreactive NST cases, because of placenta previa,
abruptio placenta and previous cesarean section. There were 155 cases with negative OCT, 84 cases with
positive OCT and 24 cases with equivocal, prolonged or severe variable decelerations. Sensitivity and
specificity were for NST 50 and 88% and for OCT 60 and 67%. The positive and negative predictive
values were 11 and 98% for NST and 18 and 93% for OCT. It is concluded that the reactive nonstress
test is a reliable test for good outcome but a positive oxytocin challenge test is not a reliable test for poor
outcome. Additional procedures are necessary such as assessment of fetal growth, doppler velocity
waveforms and fetal biophysical profile to avoid unnecessary obstetric interventions and to reach good
fetal outcome.
FHR monitoring; Non-stress test; Oxytocin challenge test; Apgar score; Sensitivity; Specificity
The results of NST in 2165 cases The relationship between NST and 5-min Apgar score
Results of NST No. of cases % Apgar score Reactive NST Nonreactive NST
TABLE VII
The statistical analysis
Test Sens. Spec. False ( + 1 False ( - 1 Post. Pre. Neg. Pre. Accuracy
rate rate value value rate
NST 50 88 88 1.65 11 98 88
OCT 60 67 82 6.0 18 93 61
negative predictive value (98.3%) than OCT. The between NST and OCT for prediction of low
difference in negative predictive value between Apgar scores and that both of them are not a
NST and OCT is statistically significant (P < reliable test for poor outcome since NST and
0.01). It means that NST is a more reliable test OCT test have a rather low positive predictive
for good outcome (98.3%) than OCT. In some value.
studies also other authors have defined that reac- Fox published that false-positive ratio, false-
tive NST was a reliable test for good outcome, negative ratio, sensitivity and specificity for OCT
Evertson et al. found that this ratio was 99% [19]. were 76, 7, 27 and 92%, respectively [26,27].
Manning et al. concluded that 96% of the NST Huddleston concluded that the false-positive rate,
cases with a reactive pattern are going to have a false-negative rate, sensitivity and specificity were
baby with an Apgar score more than 7 [20]. It was 97, 1, 50 and 81%, respectively [28]. In our study
also shown that perinatal mortality and having a we found that the false-positive rate, false-nega-
baby with a lower than seven Apgar score rates tive rate, sensitivity and specificity were 82, 6, 60
were found only in association with reactive NST and 67 for OCT test, respectively (Table VII).
pattern [9,21]. However, if deaths due to congeni- In conclusion, the general conception is that a
tal anomalies, birth trauma and neonatal sepsis negative test provides assurance that the fetus is
have been excluded, it has been found that the likely to survive and will be born in a good
surveillance rate was 99.9% for the cases of reac- condition. But the positive test result with regard
tive NST pattern [22]. Indeed, the great majority to the prediction of poor outcome is controver-
of fetus with nonreactive NST pattern have good sial. Finally, we believe that a reactive nonstress
outcome [9]. test is a reliable test for good outcome but a
Manning et al. evaluated the predictive value positive oxytocin challenge test is not a reliable
of NST according to Apgar score: The false-posi- test for poor outcome. Additional procedures are
tive rate was 2.39, positive predictive value was necessary such as assessment fetal growth,
13.1, sensitivity was 57.1, specificity was 84, nega- doppler velocity waveforms and fetal biophysical
tive predictive value was 98 and accuracy was 83.6 profile to avoid unnecessary obstetric interven-
[17]. In the present study the false-positive rate tions and to reach good fetal outcome.
was 1.65, positive predictive value was 11.15, sen-
sitivity was 50, specificity was 88, negative predic- Acknowledgement
tive value was 98 and accuracy rate was 88, re-
spectively (Table VII). Phelan et al. published
We are most grateful to Prof. Dr. H.P. van
that the false-negative rate was 1.9 and the posi-
Geijn for his advice and corrections to the paper
tive predictive value was 6.3% [23]. Brown and
in the preparatory phase.
Patrick concluded that negative predictive value
was 98.2 and positive predictive value was 85.7%
[241. Devoe et al. concluded that the negative References
predictive value was 92.8 and positive predictive
value was 30.6% [25]. Our negative predictive Rochard F, Schifrin BS, Goupil F et al. Nonstressed fetal
value is approximately the same in comparison heart monitoring in antepartum period. Am J Obstet Gy-
with the data available in literature but there are necol 1976;126:699.
Schifrin BS. Antepartum fetal heart rate monitoring. In:
some differences with regard to positive predic- Cluck L, ed. Intra-uterine asphyxia and developing fetal
tive value (11%). brain Chicago: Year Book Publishers Inc., 1977;205.
On the other hand, although OCT has a higher Kubli F, Ruttgers H, Hailer U et al. Die antepartale fetale
sensitivity rate (60%) and positive predictive value herzfrequenz II. Verhalteo-von Grundfrequenz. fluktua-
(18%) than NST (50 and ll%, respectively), there tion und dezelerationen bei antepartalem fruchttod. 2.
Geburtshilfe. Perinatol 1972;176:349.
is not any statistical difference in relation to Hammacher K, Huter KA, Bokelmann J, Werners PH.
positive predictive value between NST and OCT Fetal heart frequencies and condition of the fetus and
(P < 0.05). It means that there is no superiority newborn. Gynakologe 1968;166:349.
58
5 Hammacher K. The clinical significance of cardiotoco- 17 Manning FA, Lange IR, Morrison I, Harman CR. Fetal
graph In Perinatal Medicine. Huntingford PJ, Hunter ES, biophysical profile score and the non-stress test: a compar-
Saling E, eds. New York: Academic Press 1968;80. ative trial. Obstet Gynecol 1984;64:326.
6 Smith CU, Nguyen HN, Kovacs B, McCart D, Phelan JP, 18 Fleischer A, Schulman H, Farmakides G, Perrotta LA et
Paul RH. Fetal death following antepartum fetal heart al. Antepartum nonstress test and the postmature preg-
rate testing: a review 65 cases. Obstet Gynecol 1987;63:48,. nancy. Obstet Gynecol 1985;66:80.
7 Goldkrand JW, Benjamin DS. Antepartum fetal heart rate 19 Evertson LR, Gautheir RJ, Schifrin BS, Paul RH. An-
testing: a clinical appraisal. Obstet Gynecol 1985;66:88. tepartum fetal heart rate testing: evaluation of the non-
8 Freeman RK. The use of oxytocin challenge test for an- stress test. Am J Obstet Gynecol 1979;133:29.
tepartum clinic evaluation of uteroplacental respiratory 20 Manning FA, Platt LD, Sipos L, Keegan KA, Fetal breath-
function. Am J Obstet Gynecol 1975;124:481. ing movements and nonstress test in high risk pregnancy.
9 Schifrin B.S. The rational of antepartum fetal heart rate Am J Obstet Gynecol 1979;135:511.
monitoring. J Reprod Med 1979;23:213. 21 Schifrin BS. Antepartum fetal heart rate monitoring.
10 Martin CB, Schifrin BS. Prenatal fetal monitoring. In: Fourth International Symposium on Perinatal Medicine.
Aladjem S, Brown AK, eds. Perinatal intensive care. Co. Las Vegas. Nevada. 9-13 April 1979.
St. Louis: CV Mosby 1977;155. 22 Schifrin BS. Foye G. Amato J. Kates R. McKenna J.
11 Gabbe S, Freeman R, Goebelsman V. Evaluation of con- Routine fetal heart rate monitoring in the antepartum
traction stress test before 33 weeks gestation. Obstet Gy- period. Obstet Gynecol 1979;54:21.
necol 1978;52:649. 23 Phelan JP, Platt LD, Yeh S, Trujillo M, Paul RH. Contin-
12 Cetrolu CL, Nochimson NT. Freeman RK. Prolonged uing role of the nonstress test in the management of
pregnancy. Postgraduate course in clinic concepts in the postdates pregnancy. Obstet Gynecol 1984;64:624.
management of high-risk pregnancy. LAC-USC Medical 24 Brown R, Patrick J. The nonstress test: how long is enough
Center. Department of Ob/Gyn 1978. Am J Obstet Gynecol 1978;130:765.
13 Freeman RK, Anderson G, Dorchester W. A prospective 25 Devoe LD. Clinical implications of prospective antepar-
multinstitutional study of antepartum fetal heart rate mon- turn fetal heart rate testing. Am J Obstet Gynecol
itoring. 2. Contraction stress test versus non-stress for 1980;137:983.
primary surveillance. Am J Obstet Gynecol 1982;143:775. 26 Fox HE, Steinbrecher M, Ripton B. Antepartum fetal
14 Manning FA, Platt LD, Sipos L. Antepartum fetal evalua- heart rate and uterine activity studies. I. Preliminary re-
tion. Development of fetal biophysical profile. Am J Ob- port of acceleration and the oxytocin test. Am J Obstet
stet Gynecol 1980;136:787. Gynecol 1976;126:61.
15 Schifrin BS, Giintes (OcaklV, Gergely RC, Eden R, Roll 27 Thacker SB, Berkelman RL. Assessing the diagnostic ac-
K, Jacobs J. The role of real time scanning in antenatal curacy and efficacy of selected antepartum fetal surveil-
fetal surveillance. Am J Obstet Gynecol 1981;140:525. lance techniques. Obstet Gynecol Surv 1986;41-3:121.
16 Manning FA, Baskett TF, Morrison J et al. Fetal biophysi- 28 Huddleston JF, Sutcliff G, Camey FE et al. Oxytocin
cal profile scoring: a prospective study in 1184 high-risk challenge test for antepartum assessment. Am J Obstet
patient. Am J Obstet Gynecol 1981;140:189. Gynecol 1979;135:609.